SORRENTINO, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 449
EU - Europa 110
AS - Asia 90
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 655
Nazione #
US - Stati Uniti d'America 449
IT - Italia 47
VN - Vietnam 34
CN - Cina 31
UA - Ucraina 18
IE - Irlanda 16
TR - Turchia 12
PH - Filippine 10
SE - Svezia 8
FR - Francia 7
DE - Germania 4
ZA - Sudafrica 4
AT - Austria 2
DK - Danimarca 2
HK - Hong Kong 2
BE - Belgio 1
BG - Bulgaria 1
CO - Colombia 1
EU - Europa 1
FI - Finlandia 1
GB - Regno Unito 1
IN - India 1
LT - Lituania 1
RU - Federazione Russa 1
Totale 655
Città #
Ann Arbor 101
Chandler 88
Princeton 45
Wilmington 39
Dong Ket 34
Houston 32
Jacksonville 24
Dublin 16
Izmir 12
Fairfield 11
Nanjing 8
Woodbridge 8
Andover 7
Beijing 7
Pellezzano 7
Salerno 6
Norwalk 4
Shenyang 4
Ashburn 3
Boardman 3
Cambridge 3
Hebei 3
Jiaxing 3
Johannesburg 3
Milan 3
Boscoreale 2
Düsseldorf 2
Florence 2
Nanchang 2
Napoli 2
Nocera Inferiore 2
Pannarano 2
San Diego 2
Tianjin 2
Vienna 2
Avellino 1
Bogotá 1
Brussels 1
Castellammare Di Stabia 1
Changsha 1
Copenhagen 1
Costa Mesa 1
Dallas 1
Dearborn 1
Falls Church 1
Fremont 1
Gurgaon 1
Hangzhou 1
Highland Park 1
Kazan’ 1
London 1
Nola 1
Padula 1
Philadelphia 1
Redwood City 1
Saponara 1
Sofia 1
Stockholm 1
Vilnius 1
Totale 518
Nome #
Targeting adenosine A2b receptor reduces melanoma progression in mice: role of tumor-associated MDSCs 109
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model 108
Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target 76
Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression. 71
Soluble CD73 in the peripheral blood: a potential biomarker in patients with advanced melanoma receiving nivolumab 60
Expression of CD73 on CD8+/PD-1+cells as a new possible biomarker for advanced melanoma patients treated with nivolumab 52
Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells 52
The A2B adenosine receptor: an emerging therapeutic target in cancer 45
Expression of CD73 on MDSCs and CD8+/PD-1+cells as new possible biomarkers for advanced melanoma patients treated with nivolumab 42
Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients 35
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab 35
Notch Signaling Regulates Mitochondrial Metabolism and NF-kappa B Activity in Triple-Negative Breast Cancer Cells via IKK alpha-Dependent Non-canonical Pathways 29
Totale 714
Categoria #
all - tutte 1158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201836 0000 00 00 20709
2018/2019109 24196 59 187 146163
2019/202080 24181 11 22 210262
2020/202181 0160 63 83 31842
2021/202280 1030 13 14 712939
2022/2023175 13182125 1331 021 33000
Totale 714